USA - NASDAQ:PSTV - US72941H5090 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to PSTV. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-31 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-10-21 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-10-06 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-09-25 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-09-22 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-09-18 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-09-03 | D. Boral Capital | Upgrade | Hold -> Buy |
| 2025-08-18 | Maxim Group | Maintains | Buy -> Buy |
| 2025-06-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-06-25 | D. Boral Capital | Maintains | Hold -> Hold |
| 2025-06-05 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-05-05 | D. Boral Capital | Downgrade | Buy -> Hold |
| 2025-04-21 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-03-28 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-21 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-17 | D. Boral Capital | Initiate | Buy |
| 2024-12-09 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-11-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-03 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-08-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-30 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-03 | Maxim Group | Maintains | Buy |
| 2023-04-21 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-27 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-10-07 | JonesTrading | Initiate | Buy |
10 analysts have analysed PSTV and the average price target is 8.16 USD. This implies a price increase of 1495.31% is expected in the next year compared to the current price of 0.5115.
The consensus rating for PLUS THERAPEUTICS INC (PSTV) is 82 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering PLUS THERAPEUTICS INC (PSTV) is 10.